Abilify MyCite, the first digital pill, with a sensor digitally tracks if patients have taken their medication. Abilify MyCite also gets an approval from the US Food and Drug Administration (FDA).
This first digital pill is fitted with a digital ingestion tracking system and has an ingestible sensor embedded in the pill that records that the medication was taken.
The Abilify MyCite featuring a sensor which resembles the size of a grain of sand made of silicon, copper, and magnesium. When the sensor comes into contact with stomach acid, an electrical signal will be activated and the sensor then passes through the body naturally.
A patch the patient wears on their left rib cage receives the signal several minutes after the pill is ingested. The patch then sends data like the time the pill was taken and the dosage to a smartphone app over Bluetooth, and must be replaced every seven days.
Four other people chosen by the patient including family members, the patient’s doctor can access the information through a web-based portal. The patient can revoke access at any time.
The pill is used to address the prevalent problem of patients not taking their medication correctly.
The pill also contains a Boxed Warning, which alerts health care professionals that elderly patients with dementia-related psychosis treated with antipsychotic drugs are at an increased risk of death.
The Boxed Warning also warns about an increased risk of suicidal thinking and behavior in children, adolescents and young adults taking antidepressants.
Patients should be monitored for worsening and emergence of suicidal thoughts and behaviours.
